Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer

British Journal of Cancer

Volumn 110, Issue 4, 2014, Pages 1034-1044

  Wang, N ^a   Zhan, T ^a   Ke, T ^a   Huang, X ^b   Ke, D ^c   Wang, Q ^a,d   Li, H ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Division of Medical Oncology   (China)

^c HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PAPILLOMAVIRUS E7 PROTEINS; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84894344311     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.817     Document Type: Article

References (43)

1. Bodily JM, Mehta KP, Laimins LA (2011) Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res 71(3): 1187-1195.
2. Bosch FX, de SS (2007) The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23: 213-227.
3. Boyer SN, Wazer DE, Band V (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitinproteasome pathway. Cancer Res 56: 4620-4624.
4. Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, Paba P, Costa S, Bonifacio D, Di Bonito P, Accardi L, Favalli C, Syrjänen K. HPVPathogen ISS Study Group (2006) Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol 59: 40-47.
5. Drigotas M, Affolter A, Mann WJ, Brieger J (2013) Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response. J Oral Pathol Med 42(8): 612-619.
6. Duxbury MS, Whang EE (2007) RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness. Biochem Biophys Res Commun 354: 190-196.
7. el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B (1995) Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919.
8. Elford HL, Freese M, Passamani E, Morris HP (1970) Ribonucleotide reductase and cell proliferation. I.Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J Biol Chem245: 5228-5233.
9. Fan H, Villegas C, Huang A, Wright JA (1998) The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation. Cancer Res 58: 1650-1653.
10. Faoro V, Barbazza R, Bonin S, Brunetti D, Sulfaro S, Stanta G (2013) Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody. Appl Immunohistochem Mol Morphol 21: 341-350.
11. Garner-Hamrick PA, Fostel JM, ChienWM, Banerjee NS, Chow LT, Broker TR, Fisher C (2004) Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J Virol 78: 9041-9050.
12. Gautam A, Li ZR, Bepler G (2003) RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene 22: 2135-2142.
13. Gabellini C, Del Bufalo D, Zupi G (2006) Involvement of RB gene family in tumor angiogenesis. Oncogene 25: 5326-5332.
14. Holland D, Hoppe-Seyler K, Schuller B, Lohrey C, Maroldt J, Dürst M, Hoppe-Seyler F (2008) Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res 68: 9964-9972.
15. Huh K, Zhou X, Hayakawa H, Cho JY, Libermann TA, Jin J, Harper JW, Munger K (2007) Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol 81: 9737-9747.
16. Huh KW, DeMasi J, Ogawa H, Nakatani Y, Howley PM, Münger K (2005) Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-Associated factor, p600. Proc Natl Acad Sci USA 102: 11492-11497.
17. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
18. Kuner R, Vogt M, Sultmann H, Buness A, Dymalla S, Bulkescher J, Fellmann M, Butz K, Poustka A, Hoppe-Seyler F (2007) Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses. J Mol Med 85: 1253-1262.
19. Katich SC, Zerfass-Thome K, Hoffmann I (2001) Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene. Oncogene 20: 543-55031.
20. Landt S, Mordelt K, Schwidde I, Barinoff J, Korlach S, Stöblen F, Lichtenegger W, Sehouli J, Kümmel S (2011) Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer. Anticancer Res 31: 2651-2655.
21. Lee DJ, Kang SW (2013) Reactive oxygen species and tumor metastasis. Mol Cells 35: 93-98.
22. Liu H, Xiao J, Yang Y, Liu Y, Ma R, Li Y, Deng F, Zhang Y (2011) COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. Microvasc Res 82: 131-140.
23. Liu X, ZhangH, Lai L, Wang X, Loera S, Xue L, HeH, Zhang K, Hu S, Huang Y, Nelson RA, Zhou B, Zhou L, Chu P, Zhang S, Zheng S, Yen Y (2013) Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers. Clin Sci 124: 567-578.
24. Meng D, Mei A, Liu J, Kang X, Shi X, Qian R, Chen S (2012) NADPH oxidase 4 mediates insulin-stimulated HIF-1a and VEGF expression, and angiogenesis in vitro. PLoS One 7: E48393.
25. Morikawa T, Maeda D, Kume H, Homma Y, Fukayama M (2010) Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer. Histopathology 57: 885-892.
26. Nordlund P, Reichard P (2006) Ribonucleotide reductases. Annu Rev Biochem 75: 681-706.
27. Policht FA, Song M, Sitailo S, O'Hare A, Ashfaq R, Muller CY, Morrison LE, King W, Sokolova IA (2010) Analysis of genetic copy number changes in cervical disease progression. BMC Cancer 10: 432.
28. Ressler S, Scheiden R, Dreier K, Laich A, Müller-Holzner E, Pircher H, Morandell D, Stein I, Viertler HP, Santer FR, Widschwendter A, Even J, Jansen-Dürr P, Capesius C, Zwerschke W (2007) High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma. Clin Cancer Res 13: 7067-7072.
29. Rosty C, Sheffer M, Tsafrir D, Stransky N, Tsafrir I, Peter M, De Crémoux P, de La Rochefordière A, Salmon R, Dorval T, Thiery JP, Couturier J, Radvanyi F, Domany E, Sastre-Garau X (2005) Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene 24: 7094-7104.
30. Smola-Hess S, Pahne J, Mauch C, Zigrino P, Smola H, Pfister HJ (2005) Expression of membrane type 1 matrix metalloproteinase in papillomavirus- positive cells: Role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol 86(Pt 5): 1291-1296.
31. Tang S, Tao M, McCoy Jr. JP, Zheng ZM (2006) The E7 oncoprotein is translated from spliced E6. I transcripts in high-risk human papillomavirus type 16-or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80: 4249-4263.
32. Tang X, Zhang Q, Nishitani J, Brown J, Shi S, Le AD (2007) Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res 13: 2568-2576.
33. Thierry F, Benotmane MA, Demeret C, Mori M, Teissier S, Desaintes C (2004) A genomic approach reveals a novel mitotic pathway in papillomavirus carcinogenesis. Cancer Res 64: 895-903.
34. Tian J, Yan J, Wang W, Zhong N, Tian L, Sun J, Min Z, Ma J, Lu S (2012) T-2 toxin enhances catabolic activity of hypertrophic chondrocytes through ROS-NF-kB-HIF-2a pathway. Toxicol In Vitro 26: 1106-1113.
35. Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q (2004) Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 42: 640-645.
36. Tsai HH, Lee WR, Wang PH, Cheng KT, Chen YC, Shen SC (2013) Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-kB and AP-1 activation in macrophages. J Dermatol Sci 69: 122-131.
37. Wang F, Xu CQ, He Q, Cai JP, Li XC, Wang D, Xiong X, Liao YH, Zeng QT, Yang YZ, Cheng X, Li C, Yang R, Wang CC, Wu G, Lu QL, Bai Y, Huang YF, Yin D, Yang Q, Wang XJ, Dai DP, Zhang RF, Wan J, Ren JH, Li SS, Zhao YY, Fu FF, Huang Y, LiQX, Shi SW, Lin N, Pan ZW, Li Y, Yu B, Wu YX, Ke YH, Lei J, WangN, LuoCY, Ji LY, Gao LJ, Li L, LiuH, Huang EW, Cui J, JiaN, RenX, Li H, Ke T, Zhang XQ, Liu JY, Liu MG, Xia H, Yang B, Shi LS, Xia YL, Tu X, Wang QK (2011) Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet 43: 345-349.
38. Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
39. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH (2007) Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67: 10823-10830.
40. Xue L, Zhou B, Liu X, Wang T, Shih J, Qi C, Heung Y, Yen Y (2006) Structurally dependent redox property of ribonucleotide reductase subunit p53R2. Cancer Res 66: 1900-1905.
41. Zhang K, Hu S, Wu J, Chen L, Lu J, Wang X, Liu X, Zhou B, Yen Y (2009) Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: Implication of RRM2 in angiogenesis. Mol Cancer 8: 11-22.
42. Zhou B, Ma R, Si W, Li S, Xu Y, Tu X, Wang Q (2013) MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. Cancer Lett 333: 159-169.
43. Zhou BS, Tsai P, Ker R, Tsai J, Ho R, Yu J, Shih J, Yen Y (1998) Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential. Clin Exp Metastasis 16: 43-49.